Ponzano M - Search Results

1

Compressed sensing (CS) MP2RAGE versus standard MPRAGE: A comparison of derived brain volume measurements.

Ferraro PM, Gualco L, Costagli M, Schiavi S, Ponzano M, Signori A, Massa F, Pardini M, Castellan L, Levrero F, Zacà D, Piredda GF, Hilbert T, Kober T, Roccatagliata L. Ferraro PM, et al. Among authors: ponzano m. Phys Med. 2022 Nov;103:166-174. doi: 10.1016/j.ejmp.2022.10.023. Epub 2022 Nov 8. Phys Med. 2022. PMID: 36368208

2

Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study.

D'arminio Monforte A, Tavelli A, Sala M, Mondi A, Rusconi S, Antinori S, Puoti M, Celesia BM, Taramasso L, Saracino A, Antinori A, Cozzi-Lepri A; ICONA Foundation Study Group. D'arminio Monforte A, et al. J Antimicrob Chemother. 2023 Apr 3;78(4):933-945. doi: 10.1093/jac/dkad026. J Antimicrob Chemother. 2023. PMID: 36775983

3

Urinary phthalate and DINCH metabolite concentrations and gradations of maternal glucose intolerance.

James-Todd T, Ponzano M, Bellavia A, Williams PL, Cantonwine DE, Calafat AM, Hauser R, Quinn MR, Seely EW, McElrath TF. James-Todd T, et al. Among authors: ponzano m. Environ Int. 2022 Mar;161:107099. doi: 10.1016/j.envint.2022.107099. Epub 2022 Jan 24. Environ Int. 2022. PMID: 35085932 Free PMC article.

4

Dietary antioxidants, non-enzymatic antioxidant capacity and the risk of osteoarthritis in the Swedish National March Cohort.

Veen L, Hantikainen E, Bellocco R, Ye W, Serafini M, Ponzano M, Grotta A, Trolle Lagerros Y. Veen L, et al. Among authors: ponzano m. Eur J Nutr. 2021 Feb;60(1):169-178. doi: 10.1007/s00394-020-02239-8. Epub 2020 Apr 2. Eur J Nutr. 2021. PMID: 32242259

5

Blood-brain barrier damage associates with glia-related cytokines in the cerebrospinal fluid of patients with Multiple Sclerosis.

Puthenparampil M, Marin A, Zanotelli G, Mauceri VA, De Napoli F, Gaggiola M, Miscioscia A, Ponzano M, Bovis F, Perini P, Rinaldi F, Molon B, Gallo P. Puthenparampil M, et al. Among authors: ponzano m. Mult Scler Relat Disord. 2024 Feb;82:105403. doi: 10.1016/j.msard.2023.105403. Epub 2024 Jan 3. Mult Scler Relat Disord. 2024. PMID: 38184910 Free article.

6

What happens after fingolimod discontinuation? A multicentre real-life experience.

Landi D, Signori A, Cellerino M, Fenu G, Nicoletti CG, Ponzano M, Mancuso E, Fronza M, Ricchiuto ME, Boffa G, Inglese M, Marfia GA, Cocco E, Frau J. Landi D, et al. Among authors: ponzano m. J Neurol. 2022 Feb;269(2):796-804. doi: 10.1007/s00415-021-10658-8. Epub 2021 Jun 16. J Neurol. 2022. PMID: 34136943

7

Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study.

Palmeri S, Ponzano M, Ivaldi F, Signori A, Lapucci C, Casella V, Ferrò MT, Vigo T, Inglese M, Mancardi GL, Uccelli A, Laroni A. Palmeri S, et al. Among authors: ponzano m. CNS Drugs. 2022 Jan;36(1):83-96. doi: 10.1007/s40263-021-00875-0. Epub 2021 Dec 11. CNS Drugs. 2022. PMID: 34894339

8

Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis.

Schiavetti I, Ponzano M, Signori A, Bovis F, Carmisciano L, Sormani MP. Schiavetti I, et al. Among authors: ponzano m. Mult Scler Relat Disord. 2022 Jan;57:103358. doi: 10.1016/j.msard.2021.103358. Epub 2021 Nov 5. Mult Scler Relat Disord. 2022. PMID: 35158467 Free PMC article. Review.

9

Prevalence of disability improvement in relapsing-remitting multiple sclerosis patients treated with cladribine tablets.

Signori A, Ponzano M, Alexandri N, Giovannoni G, Sormani MP. Signori A, et al. Among authors: ponzano m. Eur J Neurol. 2022 Jul;29(7):2144-2147. doi: 10.1111/ene.15316. Epub 2022 Mar 15. Eur J Neurol. 2022. PMID: 35258154 Clinical Trial.

10

Reinterpreting Clinical Trials in Children With Multiple Sclerosis Using a Bayesian Approach.

Bovis F, Ponzano M, Signori A, Schiavetti I, Bruzzi P, Sormani MP. Bovis F, et al. Among authors: ponzano m. JAMA Neurol. 2022 Aug 1;79(8):821-822. doi: 10.1001/jamaneurol.2022.1735. JAMA Neurol. 2022. PMID: 35788638 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters